Prognostic significance of miR‐21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection. Issue 6 (1st March 2018)

• Record Type: Journal Article
• Authors: Zhang, Jiandong; Ma, Lei; Shi, Daimeng; Zhang, Zhen; Yao, Chuanshan; Zhao, Xulin; Xu, Quanxiao; Wen, Penghao; He, Limin
• Is Part Of: Journal of cellular biochemistry. Volume 119:Issue 6(2018)
• Page Start: 4783
• Page End: 4791
• Publication Date: 2018-03-01
• Subjects: miR‐21 -- prognosis -- programmed cell death 4 -- stage II esophageal carcinoma; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.26672
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Many studies have shown that randomized clinical trial with long‐term follow‐up found no improvement in stage II esophageal carcinoma (EC) patients receiving preoperative neoadjuvant chemoradiotherapy or chemotherapy treatment, this limitation underscored the urgent need for novel and reliable biomarkers for prognosis and prediction in stage II EC. miR‐21 is frequently over‐expressed while programmed cell death 4 (PDCD4) is often down‐regulated in solid tumors. This study aimed to investigate the clinicopathological and prognostic significance of miR‐21 and PDCD4 expression and to elucidate any correlation between miR‐21 and PDCD4 expression in stage II EC patients. The expression level of miR‐21 was up‐regulated while the PDCD4 protein was down‐regulated in stage II EC tissues compared with the adjacent non‐cancerous tissues. Analyses of the clinicopathological parameters indicated that miR‐21 expression was associated with differentiation grade, T stage, and N stage. PDCD4 protein expression was associated with T stage, N stage, and tumor size. The univariate linear regression analysis suggested a significant negative correlation between miR‐21 and PDCD4 expression. The Kaplan‐Meier curve showed that high miR‐21 expression or low PDCD4 expression predicted poor progression‐free survival (PFS) and overall survival (OS) of patients with stag II EC. In conclusion, both up‐regulated miR‐21 and down‐regulated PDCD4 expression were associated with the aggressive progression and poor prognosis of stage II EC. miR‐21 and PDCD4 might be potential biomarkers of tumor progression and indicators of prognosis of stag II EC. Abstract : The current study added further support to the expectation that miR‐21 or PDCD4 may be a good candidate as a molecular prognostic biomarker in stage II EC after surgical resection.